Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesKovo Healthtech Corp

Kovo Healthtech Corp

Healthcare Health Information Services
PortfolioPortfolio WatchlistWatchlist
Company price
0.005 CAD 0.00(0%)
Last update at 2026-11-03T14:30:00Z
Market Cap
1.77M

Momentum Score

…

Kovo+ Holdings Inc. operates as a healthcare technology company in the United States. The company delivers various software solutions and services, including revenue cycle management, inpatient systems, and ambulatory and eHealth software; and credentialing and hourly services, as well as electronic health records. It also offers associated services, such as electronic claim process, eligibility for reimbursement verifications, and electronic remittance advice. In addition, the company provides printing and mailing, and group purchasing services. The company provides its solutions to medical practices, facilities, clinics, and hospitals. The company was formerly known as Kovo HealthTech Corporation and changed its name to Kovo+ Holdings Inc. in October 2024. Kovo+ Holdings Inc. is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.07
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Kovo Healthtech Corp (KOVO.V) is limited; the company is listed on the TSX Venture Exchange and appears to be an early-stage health-technology issuer with few detailed disclosures about operations. Long-term growth drivers likely depend on successful product development, regulatory clearance and market adoption common to healthtech firms, and some investors may find exposure to potential medical-technology upside attractive if leadership achieves execution milestones.
Key risks include limited public disclosure, early-stage operational and execution risk, regulatory and financing uncertainty, and low liquidity typical of small-cap TSXV listings.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
10.81M
Revenue Per Share
0.07
Gross Profit TTM
2.39M
Debt / Equity
-
ROE
-1498.88%
Net Debt
13.02M
ROCE
202.94%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -6.24M -4.72M -0.91M -2.70M -1.20M
Net income -5.87M -4.68M -0.25M -2.70M -1.20M
Selling general administrative 12.88M 12.75M 11.02M 6.55M 3.61M
Reconciled depreciation 0.92M 0.79M 0.63M 0.59M 0.45M
Ebit - - - -1.26M -1.06M
Ebitda - - 0.46M -1.73M -0.42M
Operating income -3.24M -3.52M -1.10M -1.23M -1.04M
Interest expense 2.23M 0.59M 0.74M 0.38M 0.34M
Tax provision -0.37M -0.04M -0.66M - -
Net interest income -2.86M -1.04M -0.74M -0.54M -0.34M
Total revenue 10.56M 10.02M 10.55M 5.90M 3.02M
Total operating expenses 13.80M 13.54M 11.65M 7.14M 4.06M
Total other income expense net -0.14M -0.16M 0.93M -0.93M 0.18M
Net income from continuing ops -5.87M -4.68M -0.25M -2.70M -1.20M
Net income applicable to common shares - - - -2.70M -1.20M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 11.37M 9.26M 6.93M 7.33M 3.18M
Intangible assets 5.69M 4.34M 2.86M 2.97M 1.62M
Total liab 15.36M 9.56M 6.01M 7.50M 3.80M
Total stockholder equity -3.99M -0.30M 0.92M -0.17M -0.61M
Other current liab - - - 0.96M 0.32M
Common stock - - - 4.84M 2.49M
Capital stock 10.93M 8.79M 5.80M 4.84M 2.49M
Retained earnings -16.81M -10.94M -6.26M -6.01M -3.31M
Other liab - - - 0.66M 0.43M
Good will 4.73M 3.97M 2.37M 2.37M 0.98M
Other assets - - - 0.19M -
Cash 0.30M 0.10M 0.69M 0.71M 0.15M
Total current liabilities 12.97M 6.85M 2.00M 3.47M 1.68M
Net debt 13.02M 5.65M 4.20M 3.56M 2.18M
Short long term debt 10.97M 3.52M 1.00M 1.26M 0.74M
Property plant equipment - - - 0.60M 0.13M
Total current assets 0.84M 0.67M 1.19M 1.20M 0.45M
Net tangible assets - - - -5.51M -3.22M
Net receivables 0.12M 0.25M 0.28M 0.49M 0.29M
Long term debt 2.35M 2.23M 3.89M 3.01M 1.59M
Accounts payable 1.75M 3.17M 0.84M 0.99M 0.54M
Non current assets total 10.53M 8.59M 5.75M 6.14M 2.74M
Capital lease obligations 0.11M 0.26M 0.24M 0.62M 0.14M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -1.24M -3.27M -0.34M -1.40M -0.04M
Change to liabilities - - - 0.16M 0.12M
Total cashflows from investing activities - - - -1.40M -0.04M
Net borrowings 5.43M 0.18M - 1.20M 0.17M
Total cash from financing activities 5.43M 3.40M 0.74M 2.95M 0.58M
Change to operating activities - - - -0.08M -0.08M
Net income -5.87M -4.68M -0.25M -2.70M -1.20M
Change in cash 0.20M -0.59M -0.02M 0.56M 0.08M
Begin period cash flow 0.10M 0.69M 0.71M 0.15M 0.07M
End period cash flow 0.30M 0.10M 0.69M 0.71M 0.15M
Total cash from operating activities -3.98M -0.72M -0.42M -1.00M -0.46M
Issuance of capital stock 0.00M 3.22M 0.00M 1.42M 0.17M
Depreciation 0.92M 0.79M 0.63M 0.45M 0.32M
Other cashflows from investing activities - - - 0.01M 0.19M
Change to account receivables 0.13M 0.06M -0.15M -0.07M -0.01M
Change to netincome - - - 1.17M 0.22M
Capital expenditures 0.14M 0.43M 0.35M 0.16M 0.17M
Change in working capital -1.21M 2.46M -0.25M -0.08M 0.07M
Stock based compensation 0.03M 0.24M 0.48M 0.15M 0.06M
Other non cash items 2.57M 0.07M 0.27M 0.55M 0.05M
Free cash flow -4.12M -1.15M -0.77M -1.16M -0.63M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
KOVO
Kovo Healthtech Corp		 -
-%		 0.01 - - 0.16 7.48 1.93 -39.98
NURS
Hydreight Technologies Inc		 -0.18
5.96%		 2.84 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc		 -
-%		 0.35 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.		 -
-%		 0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc		 -
-%		 0.32 - - 62.75 355.42 72.08 -0.81

Profile*

Kovo Healthtech Corp

Kovo+ Holdings Inc. operates as a healthcare technology company in the United States. The company delivers various software solutions and services, including revenue cycle management, inpatient systems, and ambulatory and eHealth software; and credentialing and hourly services, as well as electronic health records. It also offers associated services, such as electronic claim process, eligibility for reimbursement verifications, and electronic remittance advice. In addition, the company provides printing and mailing, and group purchasing services. The company provides its solutions to medical practices, facilities, clinics, and hospitals. The company was formerly known as Kovo HealthTech Corporation and changed its name to Kovo+ Holdings Inc. in October 2024. Kovo+ Holdings Inc. is headquartered in Vancouver, Canada.

1600 ? 925 West Georgia Street, Vancouver, BC, Canada, V6C 3L2

800 714 0308

https://kovoplus.com

99

Name Title Year Born
Mr. Gregory Noble CEO & Director 1965
Mr. Inderjit Saini CFO & Corp. Sec. 1984
Ms. Jeana K. Noble Chief Compliance Officer 1968
Ms. Jeana K. Noble President, Founder & Chief Compliance Officer 1968
Mr. Gregory Noble Founder & Director 1965
Mr. Brenner Adams Chief Executive Officer NA
Mr. Mark Detz Chief Financial Officer NA
Ms. Denise Purvis Vice President of Operations NA
Mr. Michael A. Steele CEO & Non-Independent Director 1959
Mr. Brenner Adams Chief Strategy Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…